{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:23:54Z","timestamp":1789849434959,"version":"4.0.1"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:00:00Z","timestamp":1562544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The rate of cardiovascular disease among cancer survivors is higher than in the general population. This difference is due to traditional cardiovascular disease (CVD) risk factors and also to the cardiotoxicity of cancer treatment. In a population-based cohort study of 3,512 men and women who were free of CVD at visit 5 of a large, community-based cohort study, Florido et al. (Am J Epidemiol. 2019;188(12):2188\u20132195) evaluated the association of cancer survivorship with subclinical myocardial damage, as assessed by elevated high-sensitivity cardiac troponin T (hs-cTnT). Cancer survivors had significantly higher odds of elevated hs-cTnT (odds ratio = 1.26, 95% confidence interval: 1.03, 1.53). Results were similar for survivors of non-sex-related and colorectal cancers. There was no association between survivorship from breast and prostate cancers and elevated hs-cTnT. The findings of Florido et al. indicate that survivors of some cancers might be more likely to have elevated hs-cTnT than patients without prior cancer. These findings have important implications because identifying cancer survivors who have elevated CVD risk is of paramount importance in order to prevent CVD manifestations such as heart attack, congestive heart failure, or stroke. Additional research is needed to clarify the associations of elevated hs-cTnT levels among survivors of specific cancer sites, stage at diagnosis, and histologic types.<\/jats:p>","DOI":"10.1093\/aje\/kwz123","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T19:31:47Z","timestamp":1557862307000},"page":"367-368","source":"Crossref","is-referenced-by-count":7,"title":["Commentary: Cancer Survivorship and Subclinical Myocardial Damage"],"prefix":"10.1093","volume":"191","author":[{"given":"Steven S","family":"Coughlin","sequence":"first","affiliation":[{"name":"Department of Population Health Sciences, Medical College of Georgia, Augusta University, Augusta, Georgia"},{"name":"Institute of Public and Preventive Health, Augusta University, Augusta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaston","family":"Kapuku","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Medical College of Georgia, Augusta University, Augusta, Georgia"},{"name":"Georgia Prevention Institute, Augusta University, Augusta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,7,8]]},"reference":[{"issue":"2","key":"2022030411194774000_kwz123C1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/clc.22886","article-title":"The connection between the breast and heart in women: breast cancer and cardiovascular disease","volume":"41","author":"Gulati","year":"2018","journal-title":"Clin Cardiol"},{"issue":"8","key":"2022030411194774000_kwz123C2","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1161\/CIR.0000000000000556","article-title":"Cardiovascular disease and breast cancer: where these two entities intersect. A scientific statement from the American Heart Association","volume":"137","author":"Mehta","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"2022030411194774000_kwz123C3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11764-013-0267-9","article-title":"Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care?","volume":"7","author":"Weaver","year":"2013","journal-title":"J Cancer Surviv"},{"issue":"5","key":"2022030411194774000_kwz123C4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1634\/theoncologist.2015-0230","article-title":"Cardiotoxicity and cardiac monitoring during adjuvant trastuzumab in daily Dutch practice: a study of the Southeast Netherlands Breast Cancer Consortium","volume":"21","author":"Seferina","year":"2016","journal-title":"Oncologist"},{"issue":"3","key":"2022030411194774000_kwz123C5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12609-017-0249-4","article-title":"Incidence, diagnosis, and treatment of cardiac toxicity from trastuzumab in patients with breast cancer","volume":"9","author":"Nowsheen","year":"2017","journal-title":"Curr Breast Cancer Rep"},{"issue":"6","key":"2022030411194774000_kwz123C6","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1634\/theoncologist.2016-0406","article-title":"Cardiac safety of dual anti-HER2 therapy in the neoadjuvant setting for treatment of HER2-positive breast cancer","volume":"22","author":"Yu","year":"2017","journal-title":"Oncologist"},{"issue":"23","key":"2022030411194774000_kwz123C7","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1136\/heartjnl-2015-307848","article-title":"Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality","volume":"101","author":"Pavo","year":"2015","journal-title":"Heart"},{"issue":"11","key":"2022030411194774000_kwz123C8","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrcardio.2013.129","article-title":"Cardiac troponin level elevations not related to acute coronary syndromes","volume":"10","author":"Giannitsis","year":"2013","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"2022030411194774000_kwz123C9","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1093\/aje\/kwz088","article-title":"Cancer survivorship and subclinical myocardial damage: the ARIC Study","volume":"188","author":"Florido","year":"2019","journal-title":"Am J Epidemiol"},{"key":"2022030411194774000_kwz123C10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2147\/VHRM.S24509","article-title":"Troponin elevation in conditions other than acute coronary syndromes","volume":"7","author":"Tanindi","year":"2011","journal-title":"Vasc Health Risk Manag"}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/aje\/advance-article-pdf\/doi\/10.1093\/aje\/kwz123\/28953975\/kwz123.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/aje\/article-pdf\/191\/3\/367\/42587367\/kwz123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/aje\/article-pdf\/191\/3\/367\/42587367\/kwz123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T11:20:03Z","timestamp":1646392803000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/aje\/article\/191\/3\/367\/5529744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,8]]},"references-count":10,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,7,8]]},"published-print":{"date-parts":[[2022,2,19]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/kwz123","relation":{},"ISSN":["0002-9262","1476-6256"],"issn-type":[{"value":"0002-9262","type":"print"},{"value":"1476-6256","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3]]},"published":{"date-parts":[[2019,7,8]]}}}